Companies / Corbus Pharmaceuticals Holdings, Inc.
Corbus Pharmaceuticals Holdings, Inc.
Nasdaq: CRBPCIK 1595097NORWOOD, MA
Financials · FY2022
Ownership
19.3M shares outstanding · as of Aug 4, 2026
Ownership
| Insiders | 2.13% | 411,880 |
| 10%+ / strategic | 11.77% | 2,276,750 |
| Institutions | 65.25% | 12,620,949 |
| Public float | 20.85% | 4,031,714 |
% of common shares outstanding (exact, from the latest cover-page filing). Institutions are quarterly 13F snapshots; insiders reflect current officers & directors.
Insiders 4
View all →| Insider | % of shares | Shares |
|---|---|---|
Cohen YuvalCEOChief Executive Officer · Director | 0.90% | 174,316 |
Moran Sean F.Chief Financial Officer | 0.50% | 96,694 |
Smethurst DominicChief Medical Officer | 0.46% | 89,790 |
Hodgson IanChief Operating Officer | 0.26% | 51,080 |
Institutional holders 103
View all →| Holder | Value | % of shares |
|---|---|---|
| $19.09M | 12.12% | |
| $16.31M | 8.98% | |
| $12.49M | 6.88% | |
| $10.76M | 6.83% | |
| $7.77M | 4.94% | |
| $7.00M | 4.44% | |
| $6.86M | 4.36% | |
| $5.57M | 3.54% | |
| $4.36M | 2.77% | |
| $3.26M | 1.79% |
Activity
Jun 30, 2026View all →
InsidersInstitutions
Who's accumulating and trimming this stock (13F).| Date | Actor | Action | Security | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|---|
| Q2 2026 as of | BlackRock, Inc. 13F manager | Add | Common Stock | $9.97M | +1.1M +396.61% | 1,331,135 6.88% of shares | medium |
| Q1 2024 as of | Barclays PLC 13F manager | New | Common Stock | $7.27M | +185K | 185,148 0.96% of shares | medium |
| Q2 2024 as of | Barclays PLC 13F manager | Trim | Common Stock | $-4.23M | -93K -50.46% | 91,728 0.47% of shares | low |
| Q2 2026 as of | State Street Corporation 13F manager | Add | Common Stock | $1.87M | +200K +362.27% | 254,672 1.32% of shares | low |
| Q1 2026 as of | Orbimed Advisors LLC 13F manager | Add | Common Stock | $1.31M | +140K +8.76% | 1,737,287 8.98% of shares | low |
| Q3 2024 as of | Barclays PLC 13F manager | Trim | Common Stock | $-1.10M | -53K -58.07% | 38,462 0.20% of shares | low |
| Q1 2026 as of | Atle Fund Management AB 13F manager | Exit | Common Stock | $-873.1K | -107K -100.00% | 0 | low |
| Q1 2026 as of | Millennium Management LLC 13F manager | Add | Common Stock | $664.2K | +71K +190.84% | 107,800 0.56% of shares | low |
5%+ ownership events
Schedule 13D / 13G
| Filer | Stance | % of class |
|---|---|---|
| Octagon Capital Advisors LP | Passive13G/A | — |
| Aberdeen Group plc | Passive13G | — |
Securities
via CUSIP / OpenFIGI
| Symbol | Type | CUSIP |
|---|---|---|
| CRBP | Common Stock | 21833P301 |